Particle.news
Investment Strategies Investor Relations Series A Funding OpenAI Thrive Capital NEA Secondary Opportunity Fund Startup Valuation Series F xAI Courtside Ventures Public Offerings Unicorns Series J Funding Series B Series D LeoLabs Funding Portfolio Companies Investment Trends Series C Funding Defense Startups Defense Sector
The Alphabet subsidiary will use the funding to expand its team, enhance its AI drug design engine, and move closer to clinical trials for AI-designed treatments.
